Sp748

NON-INVASIVE TESTING FOR DETECTION OF GI CANCERS: WHERE ARE WE NOW AND WHERE WILL THE NIH VANGUARD STUDY LEAD US?

Date
May 20, 2024
Explore related products in the following collection:

Presenter


Tracks

Related Products

Thumbnail for ASSESSING THE EFFICACY OF ENDOSCOPIC GASTRIC CANCER SCREENING BY RACE AND SEX IN THE UNITED STATES
ASSESSING THE EFFICACY OF ENDOSCOPIC GASTRIC CANCER SCREENING BY RACE AND SEX IN THE UNITED STATES
Gastric cancer (GC) incidence is declining and too low in the US to recommend general population screening. However, the risk of developing GC in the US is substantially higher in ethnic minorities, potentially warranting screening in specific population subgroups. While _H…
Thumbnail for THE IMPACT OF AN ORGANIZED CANCER SCREENING PROGRAM ON GASTRIC CANCER INCIDENCE IN SEOUL, SOUTH KOREA: A SYNTHETIC CONTROL STUDY
THE IMPACT OF AN ORGANIZED CANCER SCREENING PROGRAM ON GASTRIC CANCER INCIDENCE IN SEOUL, SOUTH KOREA: A SYNTHETIC CONTROL STUDY
BACKGROUND: Evidence of gastric cancer (GC) screening’s impact on GC incidence remains limited, hindering the development of health policies for screening programs. We aimed to assess the population impact of organized GC screening programs on GC incidence in Seoul, South Korea…
Thumbnail for A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
A PROSPECTIVE, MULTI-INSTITUTIONAL STUDY REVEALS THE COMBINATION OF RNA ANALYSIS WITH DNA-BASED NEXT-GENERATION SEQUENCING (NGS) IMPROVES THE PREOPERATIVE CLASSIFICATION OF PANCREATIC CYSTS AND IDENTIFICATION OF ADVANCED NEOPLASIA
BACKGROUND: As outlined by the Kyoto guidelines, targeted DNA-based NGS of pancreatic cyst fluid (PCF) is an important adjunct to the evaluation of pancreatic cyst patients…
Thumbnail for RANDOMIZED CONTROLLED TRIAL OF FECAL IMMUNOCHEMICAL TEST (FIT)-BASED MAILED OUTREACH OFFERING ACTIVE CHOICE (FIT OR COLONOSCOPY UP-FRONT) VS. SEQUENTIAL CHOICE (INITIAL FIT, LATER INVITATION FOR COLONOSCOPY) FOR COLORECTAL CANCER (CRC) SCREENING
RANDOMIZED CONTROLLED TRIAL OF FECAL IMMUNOCHEMICAL TEST (FIT)-BASED MAILED OUTREACH OFFERING ACTIVE CHOICE (FIT OR COLONOSCOPY UP-FRONT) VS. SEQUENTIAL CHOICE (INITIAL FIT, LATER INVITATION FOR COLONOSCOPY) FOR COLORECTAL CANCER (CRC) SCREENING
BACKGROUND: Screening decreases CRC incidence and mortality, but many persons remain unscreened. Offering FIT to those who decline colonoscopy improves screening participation. Offering colonoscopy in a FIT-based program has not been studied systematically…